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EXECUTIVE SUMMARY
The goal of this experiment was to visually evaluate the effect gravity has
on delivery of medications by the use of various aerosol devices. To assist
the visual inspection of the devices, high speed video or film was to be
considered. During the preliminary ground testing in the studio it was
concluded that high speed video would notbe capable to provide sufficient
resolution of the aerosolized mist. After evaluation of the high speed film
ground test data it was determined that the ideal film speed would be 250
FPS using a 50 mm lense.
During parabolic flight the same four aerosols were retested as performed
in the studio. It appears that the Cetacaine spray and the Ventolin inhaler
function without failure during all test. The pump spray (Nostril) appeared
to function normally when the container was full however it appeared to
began to fail to deliver a full mist with larger droplet size when the
container was nearly empty. The simple hand spray bottle appeared to
work when the container was full and performed progressively worse as
the container was emptied.
During the Apollo flights they reported that "standard" spray bottles
proved to be unsatisfactory, however they did not indicate why. It appears
that we would also conclude that "standard" spray bottles do not function
as well in zero-g by failing to produce a normal mist spray. The standard
spray bottle allowed the fluid to come out in a narrow fluid stream when
held with the *nozzle either level or slightly titled upward.
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INTRODUCTION(Justification):
This proposal outlines a procedure designed to evaluate the utility of
selected aerosolized medication devices under zero gravity conditions
during KC-135 parabolic flight. Resultsobtained from thisexperiment
would be extrapolated to the situation of a continuous micro-g
environment, such as aboard Space Station Freedom. There is concern
that such devices may be inconsistent in their delivery of the
manufacturer's preset quantity of drug per unit of use (i.e.,
inhalation, puff, nozzle depression) under zero-g conditions. The
current draft of the HMF pharmaceutical formulary contains three
aerosol preparations:
1. Benzocaine 20% (topical anesthetic)
2. Albuterol (bronchodilator)
3. Nitroglycerin (vasodilator)
GOAL:
To determine if delivery of medications through use of an aerosolizing
device is an acceptable method of drug
delivery in a zero-g environment.
OBJECTIVES:
1. Compare patterns of spray dispersion under control (l-G) and zero-G
conditions).
2. Determine total available quantities of drug for each delivery system
under control (l-G) and zero-G conditions.
MATERIALS AND METHODS (Approach):
MATERIALS
Flight Crew
Three people shall be required. One investigator will work inside the glove
box while the other person shall manage exchange of materials from the
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storage bags to the glove box.
• C. Lloyd (CL)
• J. Gosbee (JG)
• High Speed Film support
Drugs
1. Benzocaine 14%, Butyl Aminobenzoate 2%, Te_acaine Hydrochloride
2% topical Anesthetic Spray (Cetacaine), manufactured by Cetylite
Industries. Average expulsion rate is 200 mg per second, (Quantity =
2 bottles). 56 gm net weight. Also contains Benzalkonium chloride 0.5%
and Cetyl dimethyl ethylammonium bromide 0.005%. Lot #299-4, Exp
Date 6/91.
° Microcrystalline suspension of albuterol Inhaler (Ventolin) 17 gm,
Allen & Hanburys, Division of Glaxo Pharmaceuticals, 200 metered
inhalations, 90 mcg/actuation, (Quantity = 2). Also contains
Trichloromonofluoromethane and dichlorodifluoro-methane. Lot
#Z13679HA, Exp Date FEB 92. (Quantity = 2)
3. Phenylephrine HCI 0.25% (NOSTRIL) Nasal Decongestant, Metered
one-way pump spray, 15 mL, Boehringer Ingelheim. Also contains
Benzalkonium chloride 0.004 %, Boric acid, Sodium borate, and water.
Lot #839001A, Exp Date JUL 92. (Quantity = 2)
. Oxymetazoline HC1 0.05% (GENASAL), AFRIN generic, nasal
decongestant spray, 30 mL, Goldine Laboratories. Also contains
Phenylmeric acetate 0.02 mg/mL.Exp Date APR 92. (Quantity = 2)
KC-135 Working Space Requirements
1. Forward in the aircraft.
2. Full width of the plane
3. At least 12 feet in length.
NOTE:
Justification for this set up is to allow for the camera(s) to be fixed mounted
and blackout curtains placed around the lense(s) to avoid any secondary
lighting to effect the filming. There will be no real-time adjustments for the
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lenses positioning in-flight. To perform this type of filming the set-up also
requires additional lighting to be in key positions around the glovebox.
Supplies
1. Glove box and supporting stand
2. Velcro material to secure drug products
3. Flat black absorbant cloth to line inside of glove box
4. Bungy cord to secure investigator in-flight
5. Duct Tape
6. Cleaning solution and towels
PROCEDURES (TO BE PERFORMED PRE- AND IN-FLIGHT)
Spray Dispersion
1. Shake pressurized container well
2. Hold the device in the appropriate orientation for administration of the
drug product and depress the plunger (command given by
photographer) to provide one to two actuations.
Positioning of the device by the investigator working in the glovebox
will be determined pre-flight and marked inside the box. The high-
speed photographer shall determine the
Repeat above procedure x 5 for each drug
Camera specs for PRE-FLIGHT testing performed in the building #8,
JSC, Photography studio:
.
4o
5.
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SHUTTER FPS SIZE (mm) #RUNS
36 100 10
36 250 10
36 250 25
36 100 25
72 100 25
72 250 25
72 250 10
72 100 10
72 100 25
72 250 25
2 of #1
2 of #1
2 of #2
2 of #2
#1-4a
#1-4a
#1-4
#1-4
#1-4
#1-4
DRUGCODE:
#1 - Cetacaine
#2 - Ventolin
#3 - Nostril
#4 - Afrin (generic)
Not all lighting was turned on during the first filming therefore these two
set-ups were repeated at the end.
. Perform still photography if possible during the filming. If this is not
possible then complete after all high-speeding filming hasbeen
completed.
GROUND SUPPORT REQUIRED
Flight (CL and JG) and Ground (Dr. Martin, T Guess and A. Freemen) crews
will need to obtain necessary supplies, prepare the test items, and perform
1 to 2 ground test pre-flight.
FLIGHT SUPPORT REQUIRED
The Ground crew will need to assist the flight crew with the set up of the
glovebox on the plane pre-flight.
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NUMBER OF FLIGHTS AND DATES DESIRED:
Number of flights: 2
Requested Dates:
First quarter of 1990
Actual Flight Dates:
March 27, 1990 (1 day)
PROJECTED RESULTS:
It is believed that the aerosols will perform properly until the pick-up stem
of the canister begins to contain air/fluid mixture secondary to the micro-
g environment. Afterwards the output should become erratic and not
deliver a full dose of the medication.
Pre-flight (1-g testing) Results
1. Glovebox and supporting materials were taken to the photography
studio in building #8 on February 20, 1990 for the pre-flight testing.
o The objective of the pre-flight testing was to determine the appropriate
film to be used, camera set-up requirements, lighting requirements and
camera settings for the in-flight filming.
3. The pre-flight testing would also modify testing procedures and identify
any additional material needs.
4. Both in-flight investigators had an opportunity to perform all in-flight
procedures while test filming was being evaluated.
5. All test articles (drug products) were filmed.
6. Additional materials needed included:
- Flat black cloth material to line the inside of the glovebox.
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7. KC-135 positioning and space requirements identified:
Forward in the aircraft.
Full width of the plane
At least 12 feet in length.
. When the Cetacaine spray bottle was turned upside done and actuated
it failed tofunction properly as soon as the pick up straw emptied. The
Ventolin Inhaler fails tospray properly within 2 puffs when operated
upside down. The pump spray and standard spray bottles are also
positional dependent and fail quickly when operated in the improper
position.
o Post shoot viewing of the film has been scheduled for Monday March
5,1990, 8 am, building #8 to determine if further ground testing shall be
required, finalize cameraset-up and specs, and in-flight procedures.
In-flight Results (March 27th)
Immediately prior to the flight velcro was placed inside the glove
box directly behind the gloves. All aerosol containers and the
containers were inspected and the fluid level was marked on each
container. Also **bungycordswere setup torestrain the investigator's
ankles while performing the testing in the box. White tape was used
to mark hand positioning to assure proper focusing of the camera. The
following revisions were made to the in-flight procedures:
1. The order containers tested would also be Cetacaine, Ventolin, Pump
container, and then Standard spray bottle.
2. During the first set of parabolas each 1/2 empty aerosol container
would be tested during to consecutive parabolas, during the first
parabola the aerosol device could be filmed immediately after entering
in to the zero-g portion of the parabola. During the second parabola the
same device would be actuated multiple times during the zero-g
portion of the parabola and filming would start in the last 10 seconds.
3. In all cases at least 3 actuations of the device would be attempted to be
filmed.
4. Starting with the second set of parabolas a set of full aerosol devices
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would be used and sprayed until empty.
Parabola Set #1:
During the first set of parabolas a large bottle of Windex window cleaner
was filmed. Since the bottle is clear plastic with a green colored fluid it was
felt it may assist us to understand what may be happening inside some of
the other containers. The Windex bottle was approximately 75% empty at
the time of testing which allowed for the fluid to move away from the pick
up straw during the parabola. Duringthe firstof 2 parabolas the solution
appeared to begin to entrain air and slowly began to migrate up the walls
of the container away from the opening in the pick up straw. This
movement and entrainment of air is believed to be secondary to the
operator pumping the spray and occasional zero-g forces. By the end of
the first parabola the majority of the fluid had moved up into the neck of the
bottle and the device began to dysfunction. During the second parabola
the investigator was instructed to swirl the fluid around prior to the
filming. This resulted in excessive foaming and entrainment of air into
the fluid. The device failed to function.
During the next three parabolas Cetacaine spray was tested. During all
tests the device appeared to function as normal. The spray stream to
remain continuous throughout each actuation. During parabolas 6 and 7
the ventolin inhaler was filmed with no notable failures.
The pump spray container was evaluated early and late during parabolas
8and 9. The operator stated that the device appeared tofail asthe Windex
bottle did when the fluid had shifted up into the neck of the bottle. The
failure was characterized as occurring sporadically and late in the parabola.
During parabola 10 the earlyphase of the parabola filming was completed
using the standard spray bottle. The device appeared to function normally.
Parabola Set #2:
During the first 2 parabolas of the second set the standard spray bottle.
It is believed that the camera lense was partially blocked by the blackout
curtain. Starting with parabola 3 the full containers were used in the order
outlined above. Filming was performed early the first parabola and late
during the second parabola for each device. It appeared that all devices
functioned without out failure except the standard spray bottle. When the
standard spray bottle was used it was actuated either with the nozzle tip
pointing slightly upward or outward with the tip level to the base of the
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glove box. This device appeared to function properly in a intermittent
fashion. One of three types of spray patterned was noted:
. Normal mist spray which forms a v-pattern was the spray leaves the
nozzle. This usually occurred when the device was predominantly full
and the nozzle tip was pointed slightly upwards.
. A simple narrow stream of liquid. This occurred if the nozzle tip was
pointed out level with the base of the glove box. It appeared to occur
when the fluid moved up into the neck of the bottle.
. Slight bubbling and little or no fluid. This occurred more and more as
the bottle was used and the residual fluid volume was furthest from the
nozzle tip.
Parabola Set #3:
During the third set of parabolas no high speed filming was performed to
allow for still photography to be completed. During the first parabola
of the third set the Windex bottle was retested. During the remainder of
the parabolas the containers were all retested. It appears that in all cases
other then the standard spray bottle the devices function normally.
Parabola Set #4
Testingand filmingonly occurred during thefirst5parabolas. At thispoint
all containers were believed to be nearly empty. The Cetacaine and
Ventolin Inhaler continued to function without a failure. The pump and
standard spray bottles failed to function properly. In both cases the device
would fail and then after several actuations the device would function
properly.
Post-flight (l-g) Results
No further testing was required.
approximate volume recorded:
Each container was emptied and the
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Partial Filled Containers
# 1 Cetacaine 8 seconds continuous
#2 Ventolin 97 puffs
#3 Nostril 8/15 mL remained
#4 Afrin (generic) 1/30 mL remained
Full Containers
#1 Cetacaine 42 seconds continuous
#2 Ventolin 192 puffs
#3 Nasalcrom 6/13 mL remained
#4 Neo-Synephrine 2/15 mL remained
It was noted during the process of determining the remaining volume in
these containers that the Ventolin bottles formed a white powder around
the nozzle opening. It has been suggested that this accumulation of powder
may result inless volume being delivered per actuation. It is suggested
during further testing that this type of product only be actuated 2 to 10
times, then the container nozzle opening be wiped off and the bottle shaken.
DISCUSSION AND CONCLUSIONS:
After reviewing the film and photographs it was determined that
pressurized aerosol containers appeared to function better than either the
standard squeeze type or pump type bottles. Other than the filming of
the Windex bottle we were unable to suggest a reason for this behavior.It
was reported in the Biomedical findings of the ApolloProgram that the
standard squeeze type dropper bottle did not function well, however there
was no comments regarding the other type of aerosol bottles evaluated
in this experiment.
It is suggested that during the second flight of this experiment the
investigators should repeat using clear bottles. To fulfill this objective the
Cetylite company has provided with Cetacaine bottles which are clear.
Other types of spray bottles will be obtained from Calmar Dispensing
Systems, makers of various sizes, shapes, and types of spray containers.
This second flight will be projected for the FY 91 HMF KC-135 fight year.
During the post-flight evaluation it was discovered that we had not
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evaluated these 1-g positional sensitive containers in different positions
during Zero-G. This testing will be answered during the second flight
as a specific objective.
The function of flying containers which were either "partial filled" or
"full" was to allow for efficient us of our flight time. However, this process
has some problems. First it was not known what the actual volume of
the containers were pre-flight nor what volume was used during flight.
therefore it was not possible to address the impact of partially filled
containers on overall usefulness as compared to use in a 1-G environment.
It did become clear during the flight that pressurized containers functioned
at various fills and to a lesser extent this was also true for the pump and
standard spray bottles. During future flights it is recommended that
comparisons be performed to the effects zero-g has on fluid sprayed in
zero-g versus 1-g testing. These volumes then may suggest potential
reduction in container usefulness in a micro-g environment. It would also
be extremely helpful to perform 1-g versus zero-gactuations of a product
like Ventolin which is report to deliver 90 mcg per actuation. This type
of test would require the cooperation of the pharmaceutical house.
REFERENCES:
1. Biomedical findings during the Apollo Program
2. Calmar Dispensing Systems, Inc. Lee's Summit, Missouri 64081, 816/
524-4160, Mary A. Murray, Sales Representative.
BUDGET SOURCE:
SD2, Medical Operations, HMF Project.
PHOTOGRAPHS:
$90-33958
Chuck Lloyd is seen secured to the floor with the use of bungy cords over
his legs. He is seen evaluating the function of the Cetacaine Spray
container inside the Glove Box. The glove box is a clear plexglass box with
rubber gloves on either end for the operator to work from. The Cetacaine
bottle can be seen actuated with a fine white spray projecting across the
box. The Cetacaine topical Anesthetic Spray bottle contains 56 grams of
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14% Benzocaine, 2% Butyl Aminobenzoate, and 2% tetracaine hydrochloride
with propellants. The spray is activated by pressing downwards on the
arm of a Jetco nozzle. This container is designed to delivers 200 mg of
medication per second. This device never appeared to fail in flight either
early or late in the parabola. Walter Cunningham is seen looking on.
$90-33959
This photograph shows Chuck Lloyd operating the Ventolin (albuterol)
Inhalation Aerosol device. Thisdevice holds 17 grams of a microcrystalline
suspension of albuterol in a trichloromonofluoromethane &
dichlorodifluoromethance propellant. The device delivers 90 mcg of
albuterol at the mouthpiece per actuation. The shot does not show the
actuation of the inhaler, however this device appeared to work properly
throughout the flight as observed on high speed film.
$90-33961
John Gosbee is seen evaluating the function of a large spray bottle after the
contains has been shaken and foam has formed inside the bottle. The
photograph wastaken withoutaflash inan attempt to highlight the spray
and the highlights from the fixed lighting. This photograph
demonstrates how easy it is to cause foaming in microgravity. It appears
that the device continues to work as seen by the faint white spray line in
the center of the photograph. However, once no further liquid remains
near the pickup straw in the bottle the device began to fail to product a full
spray pattern. The Windex bottle could easilybe operated with one hand.
$90-33962
In this photograph John Gosbee is seen operating the'Cetacaine Spray
device with theJetco nozzle under reduced lighting. As seen by the white
spray line this device appeared to function throughout the flight. This
device required the operator to use both hands, however it is believed that
the operation of this device would be much easier if operated with out the
large, bulky, rubber gloves. Once the gloves became wet the ability to hold
onto items became harder.
$90-33988
This is another attempt at obtaining a photograph of the spray form the
Ventolin Inhaler. During this attempt only the very beginning portion of
the spray pattern can be seen at the opening of the inhaler mouthpiece.
590-33989
Chuck Lloyd more clearly demonstrates the spray pattern obtained du ring
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micro-gravitywith the Cetacaine bottle. The spray pattern can be seen
to cover from the nozzle opening to other side of the glove box, where
the liquid coated the surface with benzocaine. The bottle required two
hands to operate however it was easy to actuate the device.
$90-33990
Chuck Lloyd and Walter Cunninghamevaluate the function of the Cetacaine
Spray bottle during zero-g flight. The spray pattern can be seen from the
opening of the nozzle to the other side of the glovebox.
$90-33992
From left to right, Kim Murray (SteUa-Com), John Gosbee (KRUG), and
Chuck Lloyd (NASA) floating during the last 5 parabolas of the Aerosol
flight experiment. The set-up used for this experiment was placed in the
front of the aircraft near where Kim is seen floating. The glovebox was
secured to a table mounted to the floor up against one side of the aircraft.
The high-speed camera was mounted on a pole in the center of the plane
facing the center of the glovebox. A black sheet was hung from the ceiling
in front of the camera so only the lenses struck through the sheet facing the
glovebox. Lighting was placed around the end of the glovebox closest the
front of the plane. The investigators performed their functions from the
side furthest from the front of the plane. The camera and lighting was
controlled form a rack near the front of the plane.
$90-33993
John Gosbee and Chuck Lloyd seen floating in the last 5 parabolas of the
Aerosols experiment. The blackout curtain and the camera control rack can
be seen in the background off to John Gosbee's right. The Medical Restraint
System can be seen in the foreground to John's immediate right.
$90-33996
Chuck Lloyd more clearly demonstrates the spray pattern obtained during
micro-gravity with the Cetacaine bottle. The spray pattern can be seen
to cover from the nozzle opening to other side of the glove box, where
the liquid coated the surface with benzocaine. The bottle required two
hands to operate however it was easy to actuate the device.
$90-33998
Chuck Lloyd seen evaluating the standard nasal spray bottle during zero-
g flight. The spray pattern can be seen as a broken white set of lines and
drops from the nozzle of the bottle. The spray can be seen to about mid way
in the glove box. This type of spray device appeared to work erratically.
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It appeared to function best when the bottle was full based on its ability to
delivery amist type of spray pattern. By the time the bottle was l /4 to 1/
2 full the device began to only form bubbles at the nozzle tip or delivery a
more liquid stream of fluid.
HIGH SPEED FILM
$90-023, 16mm, 200 feet, "A" Print, Aerosol Test, 1G.
$90-018, 16mm, "A" Print, Aerosol Spray Testing in Zero-G,Part I of 2.
$90-018, 16mm, "A" Print, Aerosol Spray Testing in Zero-G,Part 2 of 2.
VIDEO COPIES OF FILM:
Aerosol Spray Tests/$90-023 & 018
Master Ref #118234
SMPTE (Window) time code.
code: AEROSOL1 on (NASA 10 disc OLD) NASA 16 9-17-89
Updated 2-26-90
Updated (Chg to AEROSOL2) 3-4-90
Updated 3-30-90
Updated 6-11-90 on NASA 19 disc
Updated 8-14-90
Updated 8-18-90 and moved to c:\word4\pcs\AEROSOL2 & NASA 19
Updated 11-29-90
Updated and reformated 4-8-91
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